3Taki I-I, Maki T, Iso T, et al. Postmarketing study of nateglinide in Japan : treatment of medicationnaive patients with type 2 diabetes [ J ]. Adv Ther,2005 ;22(6) :621-35.
4Yin J, Yang G, Chen Y. Rapid and efficient chiral separation of nateglinide and its Lenantiomer on monolithic molecularly imprinted polymers [J]. J Chromatogra,2005 ;1090( 1 ) :68-75.
5Burnham MP, Johnson IT, Weston AH. Impaired small conductance Ca2+activated K + channel-dependent EDHF responses in Type 2 diabetic ZDF rats [ J ]. Br J Pharmaco1,2006 ; 148 (4) :434-41.
6Rosenstock J, Hassman DR, Madder RD,et al. Repaglinide versus.nateglinide monotherapy : a randomized, multicenter study [ J ]. Diabetes Care, 2004;27(6) :1269.
